Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
HTG Molecular Diagnostics (HTGM) PT Raised to $7 at Canaccord Genuity
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference
-
Pre-Open Movers 06/15: (HTGM) (CTIC) (YTRA) Higher; (KR) (ARNA) (GOOGL) Lower (more...)
-
HTG Molecular Diagnostics (HTGM) PT Raised to $6.50 at Canaccord Genuity
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Cuts Price Target on HTG Molecular Diagnostics (HTGM) Following In-Line 3Q Revenue
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference
-
UPDATE: Canaccord Genuity Starts HTG Molecular Diagnostics (HTGM) at Buy
-
HTG Molecular Diagnostics (HTGM) Prices 3.57M Common IPO at $14/Share
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
HTG Molecular Diagnostics (HTGM) Files $60M IPO

